Opus Genetics (IRD) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.44% |
| Dec 31, 2025 | -48.70% |
| Sep 30, 2025 | 15.85% |
| Jun 30, 2025 | 21.70% |
| Mar 31, 2025 | 11.37% |
| Dec 31, 2024 | 39.97% |
| Sep 30, 2024 | 13.69% |
| Jun 30, 2024 | -3.48% |
| Mar 31, 2024 | -20.91% |
| Dec 31, 2023 | -18.35% |
| Sep 30, 2023 | -203.89% |
| Jun 30, 2023 | -133.35% |
| Mar 31, 2023 | -101.28% |
| Dec 31, 2022 | -72.44% |
| Sep 30, 2022 | 38.34% |
| Jun 30, 2022 | 29.23% |
| Mar 31, 2022 | -82.89% |
| Dec 31, 2021 | -50.94% |
| Sep 30, 2021 | -180.13% |
| Jun 30, 2021 | -163.16% |
| Mar 31, 2021 | 3.65% |
| Dec 31, 2020 | -261.67% |
| Sep 30, 2020 | 41.93% |
| Jun 30, 2020 | 43.36% |
| Mar 31, 2020 | 38.95% |
| Dec 31, 2019 | 69.21% |
| Sep 30, 2019 | -10.73% |
| Jun 30, 2019 | 2.88% |
| Mar 31, 2019 | 14.95% |
| Dec 31, 2018 | 45.12% |
| Sep 30, 2018 | 45.85% |
| Jun 30, 2018 | 37.48% |
| Mar 31, 2018 | -14.48% |
| Dec 31, 2017 | -32.07% |
| Sep 30, 2017 | -6.38% |
| Jun 30, 2017 | -38.04% |
| Mar 31, 2017 | 24.38% |
| Dec 31, 2016 | 13.33% |
| Sep 30, 2016 | -1.65% |
| Jun 30, 2016 | 25.35% |
| Mar 31, 2016 | 16.73% |
| Dec 31, 2015 | 28.32% |
| Sep 30, 2015 | 39.70% |
| Jun 30, 2015 | 31.99% |
| Mar 31, 2015 | 26.85% |
| Dec 31, 2014 | -74.04% |
| Sep 30, 2014 | -137.70% |
| Jun 30, 2014 | -279.04% |
| Mar 31, 2014 | -230.13% |
| Dec 31, 2013 | -38.28% |
| Sep 30, 2013 | -100.15% |
| Jun 30, 2013 | -17.43% |
| Mar 31, 2013 | -21.07% |
| Dec 31, 2012 | -15.03% |
| Sep 30, 2012 | 50.68% |
| Jun 30, 2012 | 52.52% |
| Mar 31, 2012 | 51.00% |
| Dec 31, 2011 | 20.15% |
| Sep 30, 2011 | 4.19% |
| Jun 30, 2011 | -1.48% |